What is ADMA Biologics, Inc.'s Market Cap?

ADMA Biologics, Inc.'s Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.

What is ADMA Biologics, Inc.'s Enterprise Value?

ADMA Biologics, Inc.'s Enterprise Value is $2.2B, based on as-reported figures from SEC (XBRL) filings.

What is ADMA Biologics, Inc.'s Trailing P/E?

ADMA Biologics, Inc.'s Trailing P/E is 12.5×, based on as-reported figures from SEC (XBRL) filings.

What is ADMA Biologics, Inc.'s Price / Sales?

ADMA Biologics, Inc.'s Price / Sales is 4.1×, based on as-reported figures from SEC (XBRL) filings.

What is ADMA Biologics, Inc.'s EV / Revenue?

ADMA Biologics, Inc.'s EV / Revenue is 4.2×, based on as-reported figures from SEC (XBRL) filings.

What is ADMA Biologics, Inc.'s EV / EBITDA?

ADMA Biologics, Inc.'s EV / EBITDA is 9.5×, based on as-reported figures from SEC (XBRL) filings.

What is ADMA Biologics, Inc.'s Revenue (TTM)?

ADMA Biologics, Inc.'s Revenue (TTM) is $512.3M, based on as-reported figures from SEC (XBRL) filings.

What is ADMA Biologics, Inc.'s Net Income (TTM)?

ADMA Biologics, Inc.'s Net Income (TTM) is $169.0M, based on as-reported figures from SEC (XBRL) filings.

What is ADMA Biologics, Inc.'s EBITDA?

ADMA Biologics, Inc.'s EBITDA is $232.0M, based on as-reported figures from SEC (XBRL) filings.

What is ADMA Biologics, Inc.'s Diluted EPS (TTM)?

ADMA Biologics, Inc.'s Diluted EPS (TTM) is 0.75, based on as-reported figures from SEC (XBRL) filings.

ADMA Biologics, Inc. (ADMA) Financial Statements

ADMA Biologics, Inc.

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG002NCK5N4

XNAS · usd

9.43▼ 0.11 (-1.15%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close9.54

Day's Range9.41 – 9.65

52-Week Range7.21 – 20.46

Volume2.0M

Avg Volume2.1M

Share Statistics

Shares Outstanding

Employees647

ExchangeXNAS

Listed2013-10-17

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about ADMA Biologics, Inc. (ADMA)

What is ADMA Biologics, Inc.'s Market Cap?: ADMA Biologics, Inc.'s Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is ADMA Biologics, Inc.'s Enterprise Value?: ADMA Biologics, Inc.'s Enterprise Value is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is ADMA Biologics, Inc.'s Trailing P/E?: ADMA Biologics, Inc.'s Trailing P/E is 12.5×, based on as-reported figures from SEC (XBRL) filings.
What is ADMA Biologics, Inc.'s Price / Sales?: ADMA Biologics, Inc.'s Price / Sales is 4.1×, based on as-reported figures from SEC (XBRL) filings.
What is ADMA Biologics, Inc.'s EV / Revenue?: ADMA Biologics, Inc.'s EV / Revenue is 4.2×, based on as-reported figures from SEC (XBRL) filings.
What is ADMA Biologics, Inc.'s EV / EBITDA?: ADMA Biologics, Inc.'s EV / EBITDA is 9.5×, based on as-reported figures from SEC (XBRL) filings.
What is ADMA Biologics, Inc.'s Revenue (TTM)?: ADMA Biologics, Inc.'s Revenue (TTM) is $512.3M, based on as-reported figures from SEC (XBRL) filings.
What is ADMA Biologics, Inc.'s Net Income (TTM)?: ADMA Biologics, Inc.'s Net Income (TTM) is $169.0M, based on as-reported figures from SEC (XBRL) filings.
What is ADMA Biologics, Inc.'s EBITDA?: ADMA Biologics, Inc.'s EBITDA is $232.0M, based on as-reported figures from SEC (XBRL) filings.
What is ADMA Biologics, Inc.'s Diluted EPS (TTM)?: ADMA Biologics, Inc.'s Diluted EPS (TTM) is 0.75, based on as-reported figures from SEC (XBRL) filings.